BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3714778)

  • 1. Chronic exercise produces tolerance to muscarinic antagonists in rats.
    McMaster SB; Carney JM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):865-8. PubMed ID: 3714778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.
    Leander JD
    Psychopharmacology (Berl); 1981; 75(1):5-8. PubMed ID: 6795660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antagonism of the central and peripheral effects of tremorine by 2 parasympatholytics: atropine and scopolamine].
    Fontaine O; Richelle M
    Psychopharmacologia; 1967; 11(2):154-64. PubMed ID: 5588186
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between behaviorally augmented tolerance and upregulation of muscarinic receptors in the CNS: effects of chronic administration of chronic administration of scopolamine.
    Russell RW; Ehlert FJ; Hwa JJ
    Psychopharmacology (Berl); 1986; 88(1):33-9. PubMed ID: 3080776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the scopolamine stimulus in rats.
    Jung M; Perio A; Worms P; Biziere K
    Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in atropine dose effect curve after subacute soman administration.
    Modrow HE; McDonough JH
    Pharmacol Biochem Behav; 1986 Apr; 24(4):845-8. PubMed ID: 3714776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1986 Dec; 39(23):2169-76. PubMed ID: 3784773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of some diphenyl-substituted antimuscarinics: comparison with cocaine and atropine.
    Witkin JM; Genovese RF; Witkin KM; Chiang PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):377-84. PubMed ID: 1574528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise on behavioral sensitivity to carbamate cholinesterase inhibitors.
    McMaster SB; Finger AV
    Pharmacol Biochem Behav; 1989 Aug; 33(4):811-3. PubMed ID: 2616600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anticholinergic drugs on DRL performance of rhesus monkeys.
    McDonough JH
    Pharmacol Biochem Behav; 1982 Jul; 17(1):85-90. PubMed ID: 7122671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic mediation of the discriminative stimulus properties of clozapine.
    Nielsen EB
    Psychopharmacology (Berl); 1988; 94(1):115-8. PubMed ID: 3126519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
    Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
    Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinolytic antagonism to the disruptive effects of oral low doses of pyridostigmine on simple discrimination performance in rats.
    Liu WF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):745-9. PubMed ID: 1816561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in drug sensitivity following acute and chronic exercise.
    McMaster SB; Carney JM
    Pharmacol Biochem Behav; 1985 Aug; 23(2):191-4. PubMed ID: 4059304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grooming behavior induced by ACTH involves cerebral cholinergic neurons and muscarinic receptors.
    Dunn AJ; Vigle G
    Neuropharmacology; 1985 Apr; 24(4):329-31. PubMed ID: 2987726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural tolerance to arecoline in rats: cross-tolerance to oxotremorine and prevention by pretreatment with atropine.
    Overstreet DH; Jamal OS
    Psychopharmacology (Berl); 1986; 89(1):118-20. PubMed ID: 3090586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.